Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ACTRN12626000826347) titled 'UPfront tOtal eradiCation versus delAyed treatment of persistent lesions with stereotactic ablative radiotHerapy for men with metastatic (4-10) hOrmone seNsitive prosTate cancer mAnaged with best Systemic therapy: a randomised phase II trial (POCAHONTAS)' on July 9.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Open (masking not used)
Primary Sponsor: Icon Group
Condition:
Prostate cancer
Prostate cancer
Cancer - Prostate
Intervention:
Participants randomised to Arm A will receive upfront stereotactic ablative radiotherapy (SABR) to all PSM...